The successful delivery of radiation treatment involves the careful efforts of everyone on the radiation oncology team.
As a part of its Target Safely campaign, ASTRO created a series of five quality assurance and safety white papers to investigate and develop modern risk-based and process-focused quality assurance methods for radiotherapy treatment. These white papers provided an opportunity to consolidate the abundant available guidance and focus on preventing catastrophic failures.
These white papers have been endorsed by the American Association of Physicists in Medicine (AAPM), the American Association of Medical Dosimetrists (AAMD), and the American Society of Radiologic Technologists (ASRT), as well as reviewed and accepted by the American College of Radiology (ACR) Commission on Radiation Oncology. The white paper on HDR brachytherapy has also been endorsed by the American Brachytherapy Society (ABS).
An introductory paper outlining the goals of the series is available here.